Small EJ - Search Results

1

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.

Choueiri TK, Hessel C, Halabi S, Sanford B, Michaelson MD, Hahn O, Walsh M, Olencki T, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, George D, Morris MJ. Choueiri TK, et al. Among authors: small ej. Eur J Cancer. 2018 May;94:115-125. doi: 10.1016/j.ejca.2018.02.012. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29550566 Free PMC article. Clinical Trial.

2

A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma.

Small EJ, Frye JW, Wilkinson MJ, Carroll PR, Ernest ML, Stagg RJ. Small EJ, et al. Cancer. 1994 Jun 1;73(11):2803-7. doi: 10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6. Cancer. 1994. PMID: 8194022 Clinical Trial.

3

Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens.

Wolf JS Jr, Aronson FR, Small EJ, Carroll PR. Wolf JS Jr, et al. Among authors: small ej. J Surg Oncol. 1994 Jan;55(1):7-13. doi: 10.1002/jso.2930550104. J Surg Oncol. 1994. PMID: 8289458

4

A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.

Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ. Wilkinson MJ, et al. Among authors: small ej. Cancer. 1993 Jun 1;71(11):3601-4. doi: 10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#. Cancer. 1993. PMID: 8490909 Clinical Trial.

5

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.

Small EJ, Fippin LJ, Ernest ML, Carroll PR. Small EJ, et al. Cancer. 1996 Oct 15;78(8):1775-80. doi: 10.1002/(sici)1097-0142(19961015)78:8<1775::aid-cncr18>3.0.co;2-v. Cancer. 1996. PMID: 8859191 Clinical Trial.

6

The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon.

Small EJ, Weiss GR, Malik UK, Walther PJ, Johnson D, Wilding G, Kuzel T, Bajamonde A, Paton V. Small EJ, et al. Cancer J Sci Am. 1998 May-Jun;4(3):162-7. Cancer J Sci Am. 1998. PMID: 9612597 Clinical Trial.

7

Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis.

Tigrani VS, Reese DM, Small EJ, Presti JC Jr, Carroll PR. Tigrani VS, et al. Among authors: small ej. Urology. 2000 Jan;55(1):36-40. doi: 10.1016/s0090-4295(99)00395-7. Urology. 2000. PMID: 10654891

8

A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181.

Dawson NA, Conaway M, Halabi S, Winer EP, Small EJ, Lake D, Vogelzang NJ. Dawson NA, et al. Among authors: small ej. Cancer. 2000 Feb 15;88(4):825-34. Cancer. 2000. PMID: 10679652 Clinical Trial.

9

Infusional floxuridine-based therapy for patients with metastatic renal cell carcinoma.

Reese DM, Corry M, Small EJ. Reese DM, et al. Among authors: small ej. Cancer. 2000 Mar 15;88(6):1310-6. Cancer. 2000. PMID: 10717611

10

Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.

Small EJ, Lew D, Redman BG, Petrylak DP, Hammond N, Gross HM, Eastham JA, Crawford ED. Small EJ, et al. J Clin Oncol. 2000 Jul;18(13):2537-44. doi: 10.1200/JCO.2000.18.13.2537. J Clin Oncol. 2000. PMID: 10893284 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

476 results

Search Page

Filters